Browse studies, page 133
Page 133 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Advanced Glycation End Products and Their Circulating Receptors and Level of Kidney Function in Older Community-Dwelling Women American Journal of Kidney Diseases, 2008
- Advanced glycation endproducts and dicarbonyls in end-stage renal disease: associations with uraemia and courses following renal replacement therapy Clinical Kidney Journal, 2019
- Prevalence of Extended Spectrum Beta-Lactamase Producing Bacteria (ESBL) in Patients presenting with Urinary Tract Infections (UTIs) at a peri-Urban hospital, Uganda 2020
- Eating right for a healthier heart: Food choice contributes to cardiometabolic benefits and reduction of carotid intima-media thickness Nutrition (Burbank, Los Angeles County, Calif.), 2020
- Bilirubin Interference in Plasma Amino Acid Analysis by Ion Exchange Chromatography Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018
- Metabolism and global protein glycosylation are differentially expressed in healthy and osteoarthritic equine carpal synovial fluid Equine Veterinary Journal, 2021
- Beneficial Effects of Cod Protein on Inflammatory Cell Accumulation in Rat Skeletal Muscle after Injury Are Driven by Its High Levels of Arginine, Glycine, Taurine and Lysine PLoS ONE, 2013
- Metabolomic Investigation of Blood and Urinary Amino Acids and Derivatives in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease Biomedicines, 2023
- 1268-P: P-tau217 and Cognitive Function in Long-Duration Type 1 Diabetes Diabetes, 2025
- Habitual sleep quality, plasma metabolites and risk of coronary heart disease in post-menopausal women International Journal of Epidemiology, 2018
- Multi-omic analysis reveals that the CARNS1-mediated carnosine synthesis pathway modulates muscle metabolic responses to nutrient restriction in goats Animal Nutrition, 2026
- Abnormalities in lysine degradation are involved in the regulation of early stage compensated cardiac hypertrophy in pressure-overloaded rats 2021
- Urea Cycle and Arginine Metabolic Changes in COVID-19 Patients Eurasian Journal of Emergency Medicine, 2023
- Association of P53 expression with clinicopathological gradings of oral squamous cell carcinoma patients in Hyderabad Sindh The Professional Medical Journal, 2023
- Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apoB-100 particles in Finns[S] Journal of Lipid Research, 2017
- Abnormalities in lysine degradation are involved in early cardiomyocyte hypertrophy development in pressure-overloaded rats BMC Cardiovascular Disorders, 2021
- Identification of Insulin Resistance Biomarkers in Metabolic Syndrome Detected by UHPLC-ESI-QTOF-MS Metabolites, 2022
- Associations between Essential Amino Acid Intake and Functional Health Outcomes in Older Adults: Analysis of the National Health and Nutrition Examination Survey, 2001–2018 Current Developments in Nutrition, 2024
- The relationships between plasma advanced glycation end products level and cognitive function in middle-aged and elderly Chinese subjects International Journal of Hygiene and Environmental Health, 2023
- Amino Acid Intake and Conformance With the Dietary Reference Intakes in the United States: Analysis of the National Health and Nutrition Examination Survey, 2001-2018 Journal of NutriLife, 2023
- Serum Carboxymethyl-lysine, a Dominant Advanced Glycation End Product, is Associated with Chronic Kidney Disease: the Baltimore Longitudinal Study of Aging Journal of renal nutrition, 2009
- Plasma metabolomic profiling reveals a novel circulating biomarker signature in chronic pruritus of unknown origin Scientific Reports, 2024
- Association between advanced glycation end-products and depression and anxiety scores in healthy adults Proceedings of the Nutrition Society, 2025
- Fluoride exposure disrupts creatinine homeostasis and undermines the reliability of urinary metabolomics normalization Ecotoxicology and Environmental Safety, 2025
- H3K18la lactylation promotes cardiac hypertrophy through activating GATA4 signaling European Heart Journal, 2025
- Plasma advanced glycation products are associated with increased risk of depression in middle-aged and elderly Chinese adults Nutrition Research, 2025
- Correlations Between Trimethylamine-N-Oxide, Megalin, Lysine and Markers of Tubular Damage in Chronic Kidney Disease Toxins, 2025
- Deleting Titin’s C-Terminal PEVK Exons Increases Passive Stiffness, Alters Splicing, and Induces Cross-Sectional and Longitudinal Hypertrophy in Skeletal Muscle Frontiers in Physiology, 2020
- Assessment of the Usefulness of Red Cell Indices as a Screening Tool in Haemoglobin E Trait: A Cross Sectional Study International Journal of Blood Research and Disorders, 2021
- Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study PLoS ONE, 2019
- Role of Angiogenesis and Endothelialmesenchymal Transition in Bone Marrow Fibrosis Associated with Haematopoietic Neoplasms: A Cross-sectional Immunohistochemical Analysis Journal of Clinical and Diagnostic Research, 2024
- Fecal metabolomic profiles by LDL-C target achievement status in statin-treated patients: a cross-sectional study Journal of Lipid Research, 2026
- Protein content and amino acid composition in the diet of Danish vegans: a cross-sectional study BMC Nutrition, 2023
- Identifying serum amino acid as biomarkers of gestational diabetes mellitus in second-trimester among Chinese pregnant women: a machine learning-based cross-sectional study Reproductive Health, 2026
- Molecular docking based on construction of 4-a-sterol demethylase (CYP51) as an active site of Madurella mycetomatis by homology modelling 2018
- Correction to Lancet Infect Dis 2021; 21: 1129–40 The Lancet Infectious Diseases, 2021
- Textbook case of onychomycosis caused by Scopulariopsis brevicaulis The Journal of Dermatology, 2021
- Clinical use of Fosravuconazole for Patients with Onycomycosis in Our Clinic 日本臨床皮膚科医会雑誌, 2023
- Green chemistry approaches in the analytical validation of fosravuconazole using UV spectrophotometry and HPLC Green Analytical Chemistry, 2025
- Advancing Drug Therapy in Poverty-Related Diseases 2025
- An atypical case of cutaneous candidiasis caused by a face mask: With useful dermoscopic findings Journal of dermatology (Print), 2022
- Mycetoma: A Long Journey from Neglect PLoS Neglected Tropical Diseases, 2016
- Antiprotozoal drugs: challenges and opportunities Expert Opinion on Therapeutic Patents, 2023
- Multiple seborrheic keratosis‐like lesions of mycosis fungoides masquerading as the Leser–Trèlat sign Journal of dermatology (Print), 2020
- Short anagen syndrome: A unique short hair syndrome without any characteristic hair morphological abnormality Journal of dermatology (Print), 2020
- S4.5d Comparing the diagnostic performance of the commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the gold standard Medical Mycology, 2022
- S4.5c Using serum beta-glucan measurements and sequencing of the Madurella mycetomatis azole target gene to predict therapeutic outcome during azole treatment in human mycetoma Medical Mycology, 2022
- Evaluation of the New Oral Antifungal Agent Fosravuconazole in Patients with Onychomycosis : A Multicenter, Dose-Finding Study Nishi Nihon Hifuka, 2018
- Case of onychomycosis due to Candida tropicalis successfully treated using fosravuconazole Journal of dermatology (Print), 2020
- Ungual hyalohyphomycosis caused by Fusarium proliferatum successfully treated with fosravuconazole Journal of dermatology (Print), 2020
- Ungual hyalohyphomycosis caused by Penicillium citrinum successfully treated with fosravuconazole Journal of dermatology (Print), 2021
- Tinea unguium caused by terbinafine‐resistant Trichophyton rubrum successfully treated with fosravuconazole Journal of dermatology (Print), 2019
- Tinea corporis caused by terbinafine‐resistant Trichophyton rubrum successfully treated with fosravuconazole Journal of dermatology (Print), 2021
- Tinea capitis caused by Trichophyton violaceum successfully treated with fosravuconazole Journal of dermatology (Print), 2021
- Efficacy and Safety of Fosravuconazole for Onychomycosis in Elderly Patients : Nishi Nihon Hifuka, 2022
- Successful treatment of subcutaneous Purpureocillium lilacinum infection with fosravuconazole Journal of dermatology (Print), 2022
- S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—top line results Medical Mycology, 2022
- Dermatophytoma caused by terbinafine‐resistant Trichophyton rubrum treated with fosravuconazole Journal of dermatology (Print), 2022
- Treatment of Fosravuconazole for Tinea Ungium of Toes & Fingers in Hachiman Hospital for These Five Years ; The Nishinihon Journal of Dermatology, 2026
- Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial, 2024
- Successful treatment of lymphocutaneous sporotrichosis with fosravuconazole Journal of dermatology (Print), 2025
- Safety and Efficacy of a 48-Month Efinaconazole 10% Solution Treatment/Maintenance Regimen: 24-Month Daily Use Followed by 24-Month Intermittent Use Infectious disease reports, 2025
- Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models Memorias do Instituto Oswaldo Cruz, 2024
- New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial BMJ open, 2025
- A Paradigm Shift in the Treatment and Management of Onychomycosis Skin appendage disorders, 2021
- Reconstructive Surgery for the Neglected Tropical Diseases: Global Gaps and Future Directions Plastic and reconstructive surgery. Global open, 2023
- Antifungal Drugs for the Treatment of Invasive Fungal Infections-A Limited Therapeutic Toolbox Facing Growing Resistances Pharmaceuticals (Basel, Switzerland), 2025
- Association of Torsade de Pointes and QT Prolongation With Antifungal Triazoles: Analysis Using a Pharmacovigilance Database In vivo (Athens, Greece), 2023
- Cruzain Inhibitors for Chagas Disease: Anticorrelated Optimisation Landscapes and the Multiparametric Path to Clinical Candidates Chemical biology & drug design, 2026
- Design, synthesis, and biological evaluation of 2-phenylthiazole CYP51 inhibitors RSC medicinal chemistry, 2025
- In vitro profiling of Trypanosoma cruzi inhibitors identified from High throughput Screening and application to parasite painting International journal for parasitology. Drugs and drug resistance, 2026
- The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use Parasites & vectors, 2023
- Dual‐Targeting, Hybrid Antifungal Agents Targeting Candida albicans —An Overview Chemical biology & drug design, 2026
- Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey PLoS neglected tropical diseases, 2023
- In vitro and in vivo studies on the activity and selectivity of butoconazole in experimental infection by Trypanosoma cruzi Memorias do Instituto Oswaldo Cruz, 2025
- Neglected tropical diseases: recent trends and challenges associated with its rapid diagnosis and effective therapeutic strategies Frontiers in pharmacology, 2026
- Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole Mycoses, 2022
- Tinea Incognito Imitating Pustular Psoriasis in a Psoriatic Patient Following Immunosuppressive Therapy: Case Report and Narrative Review Journal of clinical medicine, 2026
- The Outcome of Aplastic Anaemia Associated with Terbinafine Therapy European journal of case reports in internal medicine, 2024
- Newer Therapies in Dermatophytosis Indian journal of dermatology, 2023
- Clinical Isolate of a Multi-Antifungal-Resistant Trichophyton rubrum Antimicrobial agents and chemotherapy, 2022
- Emerging Terbinafine Resistant Trichophyton Dermatophytosis, Testing Options and Alternative Treatments: A Systematic Review The Australasian journal of dermatology, 2025
- Parasitic diseases in heart transplantation: challenges of Toxoplasmosis and Chagas Disease JHLT open, 2026
- A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group PLoS neglected tropical diseases, 2024
- In vitro susceptibility profiles of 16 antifungal drugs against Trichophyton indotineae Microbiology spectrum, 2025
- Stress-Activated Protein Kinase Pathways as Potential Targets for the Development of New Antifungals Journal of fungi (Basel, Switzerland), 2026
- Multitarget Therapeutic Strategies for Chagas Disease: Natural Compounds, Antimicrobial Peptides, and Cell-Based Immunomodulation Infectious disease reports, 2026
- Advances and challenges in the search for new treatments for Chagas disease Memorias do Instituto Oswaldo Cruz, 2026
- Evaluation of Clinical Studies of Patients With Dermatophyte Infections Caused by Trichophyton indotineae: Treatment Response and Resistance to Antifungal Medications Dermatology practical & conceptual, 2025
- A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-κB inhibitors active against eumycetoma The Journal of antimicrobial chemotherapy, 2025
- Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay Nature communications, 2024
- Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 Inhibitors International journal of molecular sciences, 2025
- The efficacy and safety of benznidazole in adults with seropositive indeterminate form, Trypanosoma cruzi infection: a systematic review and meta-analysis BMC infectious diseases, 2025
- Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: an individual patient data meta-analysis of two proof of concept trials medRxiv, 2024
- A Strategic Partnership for Medicine Creation and Access to Medicine for Neglected Tropical Diseases Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2022
- Using (1,3)‐ β‐D ‐glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis Mycoses, 2024
- Widespread Majocchi's Granuloma Caused by Multidrug-Resistant Trichophyton rubrum Successfully Treated With Amphotericin B and Posaconazole The Journal of dermatology, 2025
- Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma Mycoses, 2022
- Onychomycosis caused by Aspergillus species belonging to section Circumdati The Journal of dermatology, 2025
- Receipt survey of prescription continuation rates for patients with onychomycosis and web-based survey of dermatologists on prescribing policies for onychomycosis therapeutics The Journal of dermatology, 2024
